For lung cancer, Opdivo is typically taken in combination with ipilimumab, and sometimes with chemotherapy made from platinum. Note: After the Food and Drug Administration (FDA) approves a ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Inhibiting lipoylation with the FDA-designated orphan drug CPI-613 (devimistat) impairs DNA repair in lung cancer cells, thereby enhancing their sensitivity to radiation in preclinical models.

Summit Therapeutics shares rallied after its lung cancer drug candidate showed that it improved patients' longevity without the disease worsening in a late-stage trial. Shares of Summit rose 11% to ...

How one man, along with his care team, turned an all-consuming cancer diagnosis into a management strategy with inspiration ...

Boehringer Ingelheim’s drug candidate for human epidermal growth factor receptor 2 (HER2)-mutated non-small cell lung cancer (NSCLC) has demonstrated a durable response of more than 14 months ...

CAMBRIDGE, MA / ACCESS Newswire / April 24, 2025 / Archetype Therapeutics, a drug discovery company that ... By targeting invasive lung cancer, these molecules can prevent metastasis.

Zongertinib conferred benefit in certain patients with previously treated HER2-mutant advanced non-small cell lung cancer in a ... letter in JAMA Oncology. Cancer drugs that received accelerated ...

such as lung cancer. These drugs influence the cell’s genetic processes, causing them to drastically reduce production of selected unwanted proteins and preventing the tumour from becoming more ...